Literature DB >> 2821365

Is multiple sclerosis the equivalent of Parkinson's disease for noradrenaline?

K Berne-Fromell1, H Fromell, S Lundkvist, P Lundkvist.   

Abstract

We have found that increasing noradrenaline (NA) levels through the use of antidepressants and 1-dopa has effects on the symptoms of MS. On these grounds we wish to present a hypothetical basis of multiple sclerosis and discuss support found in the literature. The hypothesis is that in MS there is a deficiency of NA in the synapses of the nervous system and an interruption of impulse transmission. An interruption of sufficient intensity and duration will lead to axon damage and secondary demyelination.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 2821365     DOI: 10.1016/0306-9877(87)90062-4

Source DB:  PubMed          Journal:  Med Hypotheses        ISSN: 0306-9877            Impact factor:   1.538


  5 in total

Review 1.  Mechanism of noradrenaline-induced stimulation of Na-K ATPase activity in the rat brain: implications on REM sleep deprivation-induced increase in brain excitability.

Authors:  Birendra Nath Mallick; Sudhuman Singh; Abhishek Singh
Journal:  Mol Cell Biochem       Date:  2009-10-13       Impact factor: 3.396

Review 2.  Dopamine, T cells and multiple sclerosis (MS).

Authors:  Mia Levite; Franca Marino; Marco Cosentino
Journal:  J Neural Transm (Vienna)       Date:  2017-03-10       Impact factor: 3.575

3.  Increasing CNS noradrenaline reduces EAE severity.

Authors:  Maria Vittoria Simonini; Paul E Polak; Anthony Sharp; Susan McGuire; Elena Galea; Douglas L Feinstein
Journal:  J Neuroimmune Pharmacol       Date:  2009-12-04       Impact factor: 4.147

4.  A randomised placebo controlled exploratory study of vitamin B-12, lofepramine, and L-phenylalanine (the "Cari Loder regime") in the treatment of multiple sclerosis.

Authors:  D T Wade; C A Young; K R Chaudhuri; D L W Davidson
Journal:  J Neurol Neurosurg Psychiatry       Date:  2002-09       Impact factor: 10.154

Review 5.  Neuroendocrine immunoregulation in multiple sclerosis.

Authors:  Nathalie Deckx; Wai-Ping Lee; Zwi N Berneman; Nathalie Cools
Journal:  Clin Dev Immunol       Date:  2013-12-08
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.